abstract: A negative linear association between androgen receptor (AR) function and the CAG repeat numbers is generally assumed.
Introduction
In the transactivating amino-terminal domain of the human androgen receptor (AR), a polymorphic glutamine repeat encoded by (CAG n )CAA is situated (Lubahn et al., 1988) . The mean number of CAG repeats in a given population varies with ethnicity, the normal range being approximately 10-30 in Caucasians (Giwercman et al., 1998) , slightly shorter in African-Americans and longer in Asians (Edwards et al., 1992; Lange et al., 2008) .
An abnormal elongation of the CAG bases to .40 triplets causes a disorder known as spinal and bulbar muscular atrophy or Kennedy's disease (La Spada et al., 1991) , in which AR protein aggregation in the cells occur, finally leading to death of motor neurons in the brain and spinal cord. This mainly affects the muscles, but some cases also present with hypogonadal symptoms including gynecomastia, infertility and high plasma concentrations of luteinizing hormone, follicle-stimulating hormone and estradiol (La Spada et al., 1991) . The severity of the symptoms and the progression of the disease have been inversely correlated to the extension of the CAG repeats (La Spada et al., 1992) . Notably, this correlation only seemed to apply to the neurological features of the disease and not to the features of hypogonadism and infertility.
Linking the length of this repeat to other disorders or physiological conditions has over the years accumulated in numerous conflicting reports regarding disorders of the male reproductive system, such as prostate cancer and male infertility (Stanford et al., 1997; Giwercman et al., 1998; Correa-Cerro et al., 1999; Mifsud et al., 2001) . Taken together, the cumulative results indicate that the magnitude of the risk is very small for these conditions (Zeegers et al., 2004; Davis-Dao et al., 2007) . In a very recent large European study, comprising more than 2800 men aged 40-79 years, it was found that men with longer CAG repeats had increased circulating levels of both testosterone and estradiol (Huhtaniemi et al., 2009) . This finding demonstrates the difficulties in searching for links between CAG number and phenotypical androgen dependent features, since variations in receptor activity may be blurred by parallel changes in the levels of testosterone and estradiol.
Nevertheless, it is generally believed that AR activity is inversely correlated to CAG repeat length. This assumption is supported by clinical findings in patients with Kennedy's disease and also by results of two in vitro studies. In the first study, CAG lengths of 25, 35, 49 and 77 were compared when using the viral mouse mammary tumor virus long-terminal repeat promoter and stimulating with a supra physiological concentration of 1000 nM 5a-dihydrotestosterone (DHT) (Chamberlain et al., 1994) . There was a significant difference in transactivation between the shortest and the two longest repeats, but no significant difference in activity between those in the upper normal range (25-35CAG).
In the second study, the longest repeat (31CAG) displayed decreased activity compared with the shortest (15CAG), but neither the shorter nor the longer repeat differed in capability to activate the reporter gene compared with the intermediate one (20CAG) (Tut et al., 1997) . Similar results were obtained in a more recent study, in which the activities of ARs with 15, 24 and 31 CAG repeats were compared in a range of cell lines, utilizing the probasin promoter (Beilin et al., 2000) . In the androgen sensitive prostate cancer cell line LNCaP as well as in COS-1 cells, the longest CAG generated a significantly lower amount of luciferase than the one with the shortest CAG repeat, but no difference compared with the 24CAG variant. In the androgen independent prostate cancer cell line PC3 and the breast cancer cell line MCF-7, no significant differences in function between any of the three AR variants was noted, indicating that AR activity also can be dependent on the cell system utilized and probably also on the promoter driving the reporter gene.
The conventional approach to correct for differences in transfection efficiency between different samples is to adjust for the function of a control vector that is co-transfected with the reporter gene and the transcription factor that is investigated. In addition, often also total protein amount is taken into account, to ensure that differences found do not depend on varying cell numbers between samples. However, that different control vectors also could have an impact on the reporter system is reasonable to believe. Nowadays, with the ability to assess the amount of AR protein by the enzyme linked immunosorbent assay (ELISA), the influence of CAG lengths on receptor activity could be expected to be more precisely measured by adjusting for AR protein only.
Since understanding the impact of CAG number on the AR activity is important for proper interpretation of this polymorphism and risk of pathological conditions others than Kennedy's disease, the purpose of this study was to examine the CAG lengths influence, if any, on AR activity by comparing three AR genotypes with CAG lengths in the normal range, two different transfection controls and in addition to normalizing for total protein, which is the classical procedure to date, also adjusting for AR protein content.
Materials and Methods

Study design
ARs with three CAG lengths representing a short (16CAG), a median (22CAG) and a long (28CAG) repeat together with 23GGN, which is the predominant GGN allele in many populations (Esteban et al., 2006) , were studied. The transactivating capacities of the ARs were assessed in African green monkey kidney cells (COS-1), which do not contain endogenous AR, using a luciferase reporter gene downstream of the human prostate specific antigen (PSA) promoter. Beta-galactosidase (b-gal) and Renilla luciferase (Renilla) were utilized as transfection efficiency controls. In addition to measurement of total protein, the amount of AR protein was measured by ELISA and AR mRNA was determined by real-time PCR. As the COS-1 cell line is known to metabolize testosterone, all experiments were done with the synthetic testosterone methyltrienolone (R1881) as well as with DHT. Each experiment was carried out in duplicates and repeated up to 31 times, in order to eliminate the problem of inter-assay variation.
Expression vector construction
The AR 23GGN region was amplified from 100 ng genomic human DNA by PCR under the following conditions: 1 min denaturation at 968C followed by a 1 min annealing at 568C and 3 min extension at 728C. The samples were run in an Eppendorf Mastercycler (Eppendorf, Hamburg, Germany). The program was initiated by a 3 min denaturation step at 968C and terminated with an extension step of 7 min at 728C. The PCR reaction contained 1.5 mM MgCl 2 , 200 mM of dATP, dCTP, dTTP, 100 mM of dGTP and 7-deaza-dGTP (Roche, Bromma Sweden), 1 IU of Dynazyme II (Finnzymes Oy, Espoo, Finland) and 0.5 mM of each primer, forward 5 0 -CCAGAGTCGCGACTACTACAACTTTCC-3 0 and reverse 5 0 -CCAGAACACAGAGTGACTCTGCC-3 0 (Invitrogen, Stockholm, Sweden).
PCR products were digested with Kpn1 (Roche, Bromma, Sweden) and BstE11/Eco911 (Fermentas, Helsingborg, Sweden). The digestion product of 241 bp was purified and subsequently ligated into pCMV4 expression vectors, containing the full AR cDNA sequence with CAG lengths of 16, 22 and 28, respectively, resulting in three vectors with 23GGN in combination with varying CAG lengths.
Correct incorporation was verified by direct sequencing on an ABI Prism3730 GeneticAnalyzer (Applied Biosystems, Foster City, CA, USA).
AR transactivation assay
Approximately 150 000 COS-1 cells (ECACC, Salisbury, UK) were seeded into 12-well plates 24 h before transfection and grown in Dulbeccos' modified eagle medium (DMEM) (Gibco Invitrogen, Carlsbad, CA, USA) containing 10% heat inactivated fetal bovine serum (FBS) (Saveen & Werner AB, Limhamn, Sweden) supplemented with 2 mM glutamine (PAA, Pasching, Austria) and 0.02% gentamicin (Gibco Invitrogen, Carlsbad, CA, USA).
Fugene 6 (Roche Diagnostics, Bromma, Sweden) was used for transient transfection of 200 ng of each of the pCMV4-AR constructs together with 600 ng of the pGL3-Basic Vector (Promega, Stockholm, Sweden) with a luciferase reporter gene driven by the human PSA promoter. As transfection efficiency control, 5 ng of the pRL-SV40 Renilla vector (Promega, Stockholm, Sweden) or 1 ng of the b-gal vector pCH110 (Pharmacia, Uppsala, Sweden) was used. After 24 h of incubation, the medium was changed to phenol-red free DMEM with 10% dextran-coated charcoal stripped heat inactivated FBS, 1 mM Sodium pyruvate (PAA, Pasching, Austria) and 0.02% gentamicin, in the absence or presence of 10 -100 nM DHT or 10 -100 nM R1881. Cells were lysed 48 h after transfection. Luciferase and renilla activities were assessed by the Dual Luciferase Reporter assay (Promega, Stockholm, Sweden), whereas the combination of b-gal and luciferase was assessed by the Dual Light Luciferase assay (Applied Biosystems, Stockholm, Sweden). Total protein amount was measured by the method of Bradford (BioRad, Sundbyberg, Sweden) and AR protein amount was determined with ELISA according to the description of the manufacturer (ActiveMotif, Roosevelt, Belgium).
Real-time PCR
For AR mRNA determination, total RNA was extracted from transfected cells using the RNeasy Mini Kit (Qiagen, Solna, Sweden). For preparation of cDNA from 1 mg total RNA the RevertAidFirstStrand cDNA Synthesis Kit was used with the oligo (dT) 18 primer (Fermentas, Helsingborg, Sweden). Real-time PCR was conducted with the BrilliantIISYBRGreen QPCR Master Mix (Stratagene, CA, USA) and 1 mM of each of the following primers for AR detection: forward 5 0 -AGCCTATTGCGAGAGAGCTG-3 0 , reverse 5 0 -GCTTCACTGGGTGTGGAAAT-3 0 . GAPDH was used as an endogenous control and was detected with the forward primer 5 0 -CGACCACTTTGTCAAGCTCA-3 0 and reverse primer 5 0 -AGGGGT CTACATGGCAACTG-3 0 . The real-time PCR was performed in a MX3000P thermocycler (Stratagene, CA,USA) at 958C for 10 min followed by 25 cycles at 958C for 30 s, 578C for 1 min and 728C for 1 min. The AR mRNA amount was determined by using the comparative C T method. Three samples of each genotype were analysed in triplicates and the data were compared with the expression of 22CAG treated with 10 nM DHT, which was set as a reference value.
Statistics
The activity of the most common genotype 22CAG stimulated with 10 nM of ligand was set to 100% and the mean activities of other genotypes were expressed relative to this. The results are presented as means (ranges). The Friedman test was used for over all comparison of AR function between the different CAG lengths investigated (16, 22 and 28) and the Wilcoxon signed ranks test was used for pair wise comparisons between the reference (CAG22) and the other genotypes. All statistical tests were two-tailed with statistical significance defined as P , 0.05. The data were analysed using the SPSS statistical package for Windows version 15.0 (SPSS Inc., Chicago, IL, USA).
Results
AR stimulated with 10 nm DHT, adjusted for b-gal and total protein When adjusting AR activity for b-gal and total protein, 16CAG and the 28CAG variant displayed lower mean activity compared with 22CAG [78% (range 41-132), P ¼ 0.005 and 68% (26 -162), P ¼ 0.006, respectively) (Fig. 1A) . In these experiments the AR empty control vector also showed high activity [86% (10 -166)]. These results were based on duplicate values from 12 experiments.
AR activity adjusted for renilla and total protein
When adjusting AR activity for renilla and total protein amount, the activity of 16CAG did not significantly differ from the activity of 22CAG [104% (56 -165), P ¼ 0.7] (Fig. 1B) , whereas the 28CAG variant had lower activity [59% (33 -101), P ¼ 0.004]. The empty vector displayed 17% (6-37) compared with the reference. Results were based on duplicate values from 11 experiments.
AR activity adjusted for total protein
Adjustment for total protein only resulted in the 16 and 28CAG variants exhibiting lower activities than the 22CAG [29% (11 -62), P , 0.0001, and 18% (8-40), P , 0.0001, respectively] (Fig. 2) . The results were obtained from 31 experiments with duplicate values. A similar pattern was obtained when stimulating cells with 100 nM DHT, and 28CAG 28% (26 -30) compared with 22CAG. The AR empty cells had an activity of 13% (2-24) and 17% (6 -28) when stimulated with 10 and 100 nM DHT, respectively. AR activity adjusted for AR protein AR specific protein quantified by ELISA revealed that the 22CAG variant contained the least AR protein amount in comparison to 28CAG and 16CAG. Adjusting luciferase amount for AR protein content in the cells resulted in 22CAG having the highest activity, whereas 16CAG displayed 20% (10 -47) thereof and 28CAG 12% (5-21). The P-values for both comparisons were ,0.0001 (Fig. 3) . No AR protein was detected in AR empty pCMV4 transfected cells and the activity was hence 0%. These results are based on 23 repeated experiments.
Real-time PCR, which was performed in order to determine if the differences in AR protein amount were depending on mRNA content, revealed that cells expressing 16CAG or 28CAG contained 1.7-and 1.2-fold higher amounts of AR mRNA compared with 22CAG.
AR stimulated with R1881, adjusted for renilla and total protein
After stimulation with R1881 and adjustment for renilla and total protein, the 16CAG genotype was induced to 85% (66 -127, P ¼ 0.07) of 22CAG, whereas 28CAG had an activity of 70% (50 -98, P , 0.001). The experiment was repeated eight times in duplicates. When stimulated with 100 nM R1881, a comparable pattern was found, 16CAG and 28CAG exhibiting 21% (6-35), and 19% (14-24) of 22CAG, which was used as reference. The activity of the mock transfected empty vector was negligible when using either R1881 concentration, 6% (4 -9) and 8% (4 -18), respectively.
AR activity adjusted for AR protein
After adjustment for AR protein amount, as with DHT-treatment, the most common genotype (22CAG) displayed higher activity compared with 16CAG [26% (7-63), P , 0.01] as well as to 28CAG [30% (9 -67), P ¼ 0.01]. These results are based on values from eight repeated experiments.
AR activity adjusted for total protein
A similar distribution was seen when normalising for total protein amount, 16CAG and 28CAG both generating lower activity than , P ¼ 0.01 and 34% (11 -75), P ¼ 0.01, respectively]. The mock was 8% (5-14). These results are based on duplicate values from eight repeated experiments.
Discussion
The main finding of current work was that the CAG repeat number was not inversely associated with the capability of the AR to drive a reporter gene in vitro. The obtained activity patterns showed that one of the most frequent CAG lengths in most, if not all, studied populations so far (Edwards et al., 1992; Lundin et al., 2003; Lange et al., 2008) also had the highest activity in vitro. This result was parallel to previous findings concerning the other polymorphic region in exon 1-the GGN repeat. Also for this triplet, the most common variant (23GGN) was in vitro found to give the most efficient receptor (Lundin et al., 2007) .
It has been proposed that since 91 -99% of the CAG alleles across different ethnic groups are between 16 and 29 residues; this could be a range that would maintain maximum interaction between the transactivating domain and hormone binding domain of the AR, whereas shorter or longer repeats than the critical range of 16-29 residues could be a more important mediator of disease phenotype than a stepwise reduction in activity with increasing CAG length across the entire range (Buchanan et al., 2004) . In our study, the AR variants in the upper and lower normal range were functionally inhibited compared with the one with median CAG-length. Whether this ever can be found in humans at physiological conditions needs to be investigated. In healthy individuals, any impairment in AR functionality can be compensated by activation of the hypothalamic-pituitary-testis axis and eventually higher androgen levels and/or probably also by regulating the amount of AR expressed. We found lower amount of AR mRNA and protein in the CAG22 variant than in those in the lower or upper normal range indicating that at least within this CAG range, even in an experimental setting, differences in function can be compensated for by higher AR expression. In that context, our results support the suggestion by Buchanan and co workers, that normal AR function is sustained over a critical, but limited, range of CAG lengths and could be a plausible explanation to why analysis of this polymorphism and diseases such as male infertility and prostate cancer have produced so many conflicting results.
Our experiments also showed, that in experimental settings, selection of the method for adjustment for transactivation efficiency may highly influence the final conclusions drawn. Thus, when using the commonly applied combination of total protein measurement in combination with either b-galactosidase or renilla-luciferase as transfection controls, results which very much resemble those in previous reports were obtained (Tut et al., 1997) . However, with these vectors included in the system, also the vector lacking the AR showed considerable background activity, why these results must be considered as highly uncertain. With b-galactosidase the background was almost as high as the AR induced function, meaning that in our hands this control vector could not be used. This was also confirmed when testing for AR protein in that no AR was detectable with ELISA in empty mock transfected cells. By only adjusting for total protein amount, a pattern close to that of the ELISA-experiments was obtained, which might be a more cost-efficient way to handle data. In summary, we found that median CAG length resulted in highest AR mediated transcription, but least AR protein compared with longer and shorter repeats. Thus, analysis of CAG repeat lengths in linear regression models, as performed in most studies, probably is not valid and that stratifying the data would be an alternative way of testing and re-analysing existing CAG repeat data and possible association to disease.
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